.Pharmacolibrary.Drugs.ATC.A.A06AX08

Information

name:Tenapanor
ATC code:A06AX08
route:oral
compartments:1
dosage:50mg
volume of distribution:1L
clearance:0L/h
other parameters in model implementation

Tenapanor is an inhibitor of the sodium/hydrogen exchanger 3 (NHE3) located in the intestines, approved for the treatment of adults with irritable bowel syndrome with constipation (IBS-C) and, in some regions, for hyperphosphatemia in chronic kidney disease patients on dialysis.

Pharmacokinetics

Healthy adults, both sexes, evaluated after oral administration; tenapanor has minimal systemic absorption, thus systemic exposure is negligible.

References

    Revisions


    Generated at 2025-08-11T18:21:04Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos